Basics |
Company: |
Arrowhead Pharmaceuticals, Inc. |
IPO Date: |
July 6, 2000 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$2.33B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.45 | 3.25%
|
Avg Daily Range (30 D): |
$0.45 | 2.27%
|
Avg Daily Range (90 D): |
$0.49 | 2.32%
|
Institutional Daily Volume |
Avg Daily Volume: |
.7M |
Avg Daily Volume (30 D): |
1.46M |
Avg Daily Volume (90 D): |
1.25M |
Trade Size |
Avg Trade Size (Sh.): |
118 |
Avg Trade Size (Sh.) (30 D): |
80 |
Avg Trade Size (Sh.) (90 D): |
69 |
Institutional Trades |
Total Inst.Trades: |
4,681 |
Avg Inst. Trade: |
$3.19M |
Avg Inst. Trade (30 D): |
$5.59M |
Avg Inst. Trade (90 D): |
$3.9M |
Avg Inst. Trade Volume: |
.1M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$5.48M |
Avg Closing Trade (30 D): |
$8.8M |
Avg Closing Trade (90 D): |
$5.32M |
Avg Closing Volume: |
172.08K |
|
|
|
|
Financials |
|
TTM |
Q4 2024 |
FY 2024 |
Basic EPS
|
$-5
|
$-1.37
|
$-5
|
Diluted EPS
|
$-5
|
$-1.37
|
$-5
|
Revenue
|
$ 3.55M
|
$ M
|
$ 3.55M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -609.69M
|
$ -173.34M
|
$ -609.69M
|
Operating Income / Loss
|
$ -601.08M
|
$ -162.2M
|
$ -601.08M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -8.21M
|
$ 33.29M
|
$ -8.21M
|
PE Ratio
|
|
|
|
Splits |
Nov 17, 2011:
10:1
|
Jan 15, 2004:
65:1
|
|